Hepatocellular Carcinoma: A Rapidly Evolving Treatment Landscape

home / peer-exchange / hepatocellular-carcinoma-a-rapidly-evolving-treatment-landscape

The Complexity of HCC Multidisciplinary Management

EP. 1: The Complexity of HCC Multidisciplinary Management

October 30th 2020
Screening Vs Diagnosis: Assessing Liver Function

EP. 2: Screening Vs Diagnosis: Assessing Liver Function

October 30th 2020
The BCLC Staging System

EP. 3: The BCLC Staging System

October 30th 2020
The TACE Approach for Intermediate-Stage Disease

EP. 4: The TACE Approach for Intermediate-Stage Disease

October 30th 2020
Optimal HCC Frontline Treatments

EP. 5: Optimal HCC Frontline Treatments

October 30th 2020
Choosing a Frontline Therapy

EP. 6: Choosing a Frontline Therapy

October 30th 2020
NCCN Guidelines: Nivolumab in Frontline Setting

EP. 7: NCCN Guidelines: Nivolumab in Frontline Setting

October 30th 2020
Importance of Endoscopy in Newly Diagnosed HCC

EP. 8: Importance of Endoscopy in Newly Diagnosed HCC

October 30th 2020
Promising Ongoing Frontline Trials

EP. 9: Promising Ongoing Frontline Trials

October 30th 2020
Second-Line Options After IMbrave150 Regimen

EP. 10: Second-Line Options After IMbrave150 Regimen

October 30th 2020
Immunotherapy Monotherapy in Later-Line Setting

EP. 11: Immunotherapy Monotherapy in Later-Line Setting

October 30th 2020
High AFP as Deciding Factor for Treatment

EP. 12: High AFP as Deciding Factor for Treatment

October 30th 2020
Developing Trial Regimens for Chinese Populations

EP. 13: Developing Trial Regimens for Chinese Populations

October 30th 2020
Evolving HCC Treatment Landscape: Combination Therapy

EP. 14: Evolving HCC Treatment Landscape: Combination Therapy

October 30th 2020